Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.
about
Antibiotics for exacerbations of chronic obstructive pulmonary diseaseBronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-AnalysisMoxifloxacin modulates inflammation during murine pneumonia.Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD AuditPrognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based StudyImpact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trialPharmacological Management and Prevention Of Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients.Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis and COPD: a systematic review and meta-analysisThe use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.The pharmacological approach to the elderly COPD patient.Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease.Pharmacotherapy for lower respiratory tract infections.Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease.Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice.Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids.The Clinical Management Of Lower Respiratory Tract Infections.Acute exacerbations of COPD: risk factors for failure and relapse.Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD.Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis.Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary DiseaseEfficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease
P2860
Q24202248-5C66C9C0-508B-43EF-8E7A-535C3A1B663DQ26765486-EF4A35E9-DCCD-4FF2-A65E-B216093D625CQ33986123-3343F23E-40DE-42EC-9846-0359123796ABQ34560033-F475B73E-03B0-4C0C-A94C-1F532C27E377Q35533063-822C3E2E-0DAE-4A80-9E73-9C52894DE57EQ35694431-C036B010-7518-432E-B38D-F26AA0C47145Q35754952-BFAF38C6-C861-4F51-BB62-A8087A03C8D8Q36272425-6069EA6B-9AB0-4028-8B20-40BD581E64B2Q36526951-4755C29D-E8DD-4E32-8E47-B3396BBB6CD0Q36763617-48FB0770-576E-4505-8104-F4B26D6336E9Q37372207-E54E9189-6A58-4A10-B17C-E0571691C58DQ37582484-F2457ECF-6C5F-4CA1-951C-AA446191B196Q37629535-4A82E7B3-93F3-4431-81C1-D1D1B2CCC08AQ38056764-A6AA43B4-2F24-4C9B-A290-7CCCE8C2A261Q38098479-ED739CAB-AD7E-4348-9E9B-1EA41FD3993BQ38169246-B2DE3687-F1FF-4520-8E3F-9612B8DCF3E9Q38248719-C12B283D-E2F2-4184-8A4C-A90CA59EFC80Q38667550-7BCEC4BA-7C08-4A2D-BE1A-D93F7147A660Q39370816-E8385775-E8C0-4032-B9BA-DA1F514A8112Q40260675-33D5D498-879E-4632-9C63-A8132A750EC3Q40448715-A2CE4D06-5B29-4A6D-9B53-40D93D6D4251Q40785029-A9F540E3-CF7D-4675-AAB2-4584730E7561Q41072489-543285E5-37EB-4B77-841F-1935AFE84D39Q41367451-97EB485C-E2FA-43F6-9D45-4CEE159808FDQ43518845-CD66D2DC-5BC0-433F-81E9-8D98BFC78F92Q47127548-44B578BD-9113-42E5-BA01-F3C9326E7426Q54998966-BE489AE9-1A1B-44F9-B097-EAB6E053AB28Q57777724-99935385-988A-4841-A677-BB296B4B7456Q57777851-E654760B-B1AB-4769-ADBA-97D2D900FB87
P2860
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.
@ast
Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.
@en
type
label
Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.
@ast
Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.
@en
prefLabel
Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.
@ast
Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.
@en
P2093
P2860
P1476
Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.
@en
P2093
Daniel Haverstock
Jeff Alder
Mila Trajanovic
Pierre Arvis
Robert Wilson
Sanjay Sethi
P2860
P356
10.1183/09031936.00090311
P577
2011-12-01T00:00:00Z